期刊文献+

3.0TMR标准化表观扩散系数值评价肝纤维化程度的研究 被引量:21

Diffusion weighted imaging for quantification of liver fibrosis in patients using normalized apparent diffusion coefficient values at 3.0 T MR
原文传递
导出
摘要 目的探讨标准化ADC值对肝纤维化程度定量分析的能力。方法采用3.0TMRDWI检查回顾性分析10名健康志愿者(对照组)和43例经肝脏穿刺活检病理证实为肝功能代偿期的肝病患者(慢性肝病组)资料,慢性肝病组患者进行肝纤维化分期(S分期)。测量不同肝纤维化分期下肝脏ADC值、脾脏ADC值、肾皮质ADC值、脾脏标准化ADC值(S-ADC)及肾脏标准化ADC值(R—ADC)。采用非参数Spearman检验分析S分期与ADC值之间的相关性;采用单因素方差分析比较各期ADC值间的差异,采用Logistic回归分析评价ADC值预测纤维化程度的能力,选择约登指数最大作为截断点,计算曲线下面积(AUC)、敏感度及特异度。结果10名对照组志愿者均为S0期。慢性肝病组S0、S1、S2、S3、S4期分别有2、5、9、12和15例。S0-S4期肝脏ADC值分别为(1.37±0.13)×10^-3、(1.33±0.16)×10^-3、(1.17±0.16)×10^-3、(1.23±0.14)×10^-3和(1.12±0.11)×10^-3mm^2/s,S—ADC分别为1.86±0.18、1.68±0.12、1.3±0.14、1.48±0.15和1.34±0.10,R—ADC分别为0.71±0.08、0.68±0.12、0.61±0.09、0.64±0.11和0.60±0.08,差异均有统计学意义(F值分别为6.48、18.70和3.04,P〈0.05)。S-ADC、肝脏ADC值和R—ADC均与肝纤维化分期呈负相关性(r值分别为-0.71、-0.51和-0.41,P值均〈0.01),但S-ADC与肝纤维化分期的相关性高于肝脏ADC值和R-ADC。对于预测≥S2期、≥S3期及S4期纤维化,S-ADC的效果均优于肝脏ADC值、R—ADC,约登指数分别为0.91、0.58和0.59。结论S-ADC在评价肝纤维化方面优于肝脏ADC值及R—ADC,具有良好的诊断准确性。 Objective The purpose of this study is to discuss the diagnostic accuracy of normalized liver ADC using the spleen and renal cortex as reference organs for the diagnosis of liver fibrosis. Methods Forty three patients with liver disease (chronic liver disease group) at compensated stage and 10 healthy volunteers (control group) were retrospectively assessed with diffusion-weighted imaging at a 3.0 T MR unit. Liver ADC, spleen ADC, renal ADC and normalized ADC ( defined as the ratio of liver ADC to spleen ADC or renal cortex ADC, S-ADC and R-ADC for short) were measured in patients stratified by fibrosis stage. Spearman analysis was used to see the correlation between fibrosis stages and ADC, one-way ANOVA was used to compare the ADCs in different fibrosis stages. Logistic regression analysis was used to determine the performance of ADC for prediction of liver fibrosis, and show the area under the curve (AUC) , sensitivity and specificity choosing the optimal cutoff value that maximized the Youden index. Results Ten volunteers belonged to SO stage. From SO to $4 stage, there were 2, 5, 9, 12 and 15 patients, correspondingly, liver ADC were (1.37±0.13) ×10-3, (1.33±0.16) ×10-3, (1.17±0.16) ×10-3, (1.23±0.14) ×10-3 and (1. 12 ±0. 11) × 10 -3mm2/s, S-ADC were 1. 86 ±0. 18, 1. 68 ±0. 12, 1. 34 ±0. 14, 1.48 ±0. 15 and 1.34±0. 10, R-ADC were 0.71 ±0.08, 0.68 ±0.12, 0.61 ±0.09, 0.64 ± 0. 11 and 0.60 ±0.08 respectively, and the differences among them were significant (F = 6.48, 18.70 and 3.04 ,P 〈 0. 05 ). Thecorrelation between fibrosis stage and S-ADC was stronger than between fibrosis stage and liver ADC, R-ADC (r = -0. 71, -0. 51, -0. 41 ;P 〈 0. 01 ) . S-ADC was superior to liver ADC and R-ADC for detection of S2, S3 and S4 fibrosis stage (Youden index: 0. 91, 0. 58, and 0. 59). Conclusion Spleen normalized liver ADC improves diagnostic accuracy for detection of liver fibrosis than liver ADC and renal normalized liver ADC.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2012年第4期322-326,共5页 Chinese Journal of Radiology
基金 基金项目:国家自然科学基金资助项目(81071123)
关键词 肝硬化 磁共振成像 对比研究 Liver cirrhosis Magnetic resonance imaging Comparative study
  • 相关文献

参考文献10

  • 1Taouli B,Koh DM. Diffusion-weighted MR imaging of the liver[J].Radiology,2010.47-66.
  • 2Rosenkrantz AB,Oei M,Babb JS. Diffusion-weighted imaging of the abdomen at 3.0 Tesla:image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla[J].Journal of Magnetic Resonance Imaging,2011.128-135.doi:10.1002/jmri.22395.
  • 3Do RK,Chandarana H,Felker E. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging:value of normalized apparent diffusion coefficient using the spleen as reference organ[J].American Journal of Roentgenology,2010.671-676.doi:10.2214/AJR.09.3448.
  • 4中华医学会传染病与寄生虫病学分会;中华医学会肝病学分会.病毒性肝炎防治方案[J]中华传染病杂志,200156-62.
  • 5黄仲奎,陆力坚,龙莉玲.慢性肝病及其肝功能储备的扩散加权成像研究[J].中华放射学杂志,2010,44(12):1263-1267. 被引量:12
  • 6Papanikolaou N,Gourtsoyianni S,Yarmenitis S. Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions:value of normalization with spleen[J].European Journal of Radiology,2010,(2):305-309.doi:10.1016/j.ejrad.2008.10.023.
  • 7Lewin M,Poujol-Robert A,Bo(e)lle PY. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C[J].Hepatology,2007,(3):658-665.doi:10.1002/hep.21747.
  • 8Huwart L,Sempoux C,Vicaut E. Magnetic resonance elastography for the noninvasive staging of liver fibrosis[J].Gastroenterology,2008,(1):32-40.doi:10.1053/j.gastro.2008.03.076.
  • 9石喻,郭启勇,廖伟,马跃,乞文旭.MR扩散加权成像评价慢性病毒性肝炎肝纤维化的临床研究[J].中华放射学杂志,2010,44(1):65-69. 被引量:18
  • 10Dale BM,Braithwaite AC,Boll DT. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen[J].Investigative Radiology,2010,(2):104-108.doi:10.1097/RLI.0b013e3181c8ceac.

二级参考文献16

共引文献27

同被引文献153

  • 1曾民德,陆伦根,茅益民.肝纤维化的诊断方法及其评估(上)[J].肝脏,2006,11(2):102-105. 被引量:15
  • 2王秋实,郭启勇,梁长虹,刘辉,廖伟.MR弥散加权成像在兔肝纤维化模型中的初步实验研究[J].中国医学影像技术,2007,23(7):952-955. 被引量:23
  • 3Hussain SM,Semelka RC. Hepatic imaging : comparison ofmodalities. Radiol Clin North Am,2005 ,43 :929-947.
  • 4Koinuma M, Ohashi I,Hanafusa K,et al. Apparent diffusioncoefficient measurements with diffusion-weighted magneticresonance imaging for evaluation of hepatic fibrosis. J Magn ResonImaging,2005 ,22 :80-85.
  • 5Annet L, Peeters F, Abarca-Quinones J, et al. Assessment ofdiffusion-weighted MR imaging in liver fibrosis. J Magn ResonImaging,2007,25 :122-128.
  • 6Girometti R, Furlan A,Bazzocchi M,et al. Diffusion-weighted MRIin evaluating liver fibrosis: a feasibility study in cirrhoticpatients. Radiol Med ,2007,112 :394408.
  • 7Asbach P,Hein PA,Stemmer A,et al. Free-breathing echo-planarimaging based diffusion-weighted magnetic resonance imaging ofthe liver with prospective acquisition correction. J Comput AssistTomogr,2008,32 :372-378.
  • 8Lewin M, Poujol-Robert A,Boelle PY, et al. Diffusion-weightedmagnetic resonance imaging for the assessment of fibrosis inchronic hepatitis C. Hepatology ,2007 ,46 :658-665.
  • 9Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and earlymonitoring of tumor response to therapy in mice. Radiology, 2004,232:685-692.
  • 10Do RK, Chandarana H, Felker E, et al. Diagnosis of liver fibrosisand cirrhosis with diffusion-weighted imaging : value of normalizedapparent diffusion coefficient using the spleen as referenceorgan. AJR Am J Roentgenol ,2010,195 : 671-676.

引证文献21

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部